Literature DB >> 12488443

Palmitoylation of the human prostacyclin receptor. Functional implications of palmitoylation and isoprenylation.

Sinead M Miggin1, Orlaith A Lawler, B Therese Kinsella.   

Abstract

We have previously established that isoprenylation of the prostacyclin receptor (IP) is required for its efficient G protein coupling and effector signaling (Hayes, J. S., Lawler, O. A., Walsh, M. T., and Kinsella, B. T. (1999) J. Biol. Chem. 274, 23707-23718). In the present study, we sought to investigate whether the IP may actually be subject to palmitoylation in addition to isoprenylation and to establish the functional significance thereof. The human (h) IP was efficiently palmitoylated at Cys(308) and Cys(311), proximal to transmembrane domain 7 within its carboxyl-terminal (C)-tail domain, whereas Cys(309) was not palmitoylated. The isoprenylation-defective hIP(SSLC) underwent palmitoylation but did not efficiently couple to G(s) or G(q), confirming that isoprenylation is required for G protein coupling. Deletion of C-tail sequences distal to Val(307) generated hIP(Delta307) that was neither palmitoylated nor isoprenylated and did not efficiently couple to G(s) or to G(q), whereas hIP(Delta312) was palmitoylated and ably coupled to both effector systems. Conversion of Cys(308), Cys(309), Cys(311), Cys(308,309), or Cys(309,311) to corresponding Ser residues, while leaving the isoprenylation CAAX motif intact, did not affect hIP coupling to G(s) signaling, whereas mutation of Cys(308,311) and Cys(308,309,311) abolished signaling, indicating that palmitoylation of either Cys(308) or Cys(311) is sufficient to maintain functional G(s) coupling. Although mutation of Cys(309) and Cys(311) did not affect hIP-mediated G(q) coupling, mutation of Cys(308) abolished signaling, indicating a specific requirement for palmitoylation of Cys(308) for G(q) coupling. Consistent with this, neither hIP(C308S,C309S), hIP(C308S,C311S), nor hIP(C308S,C309S,C311S) coupled to G(q). Taken together, these data confirm that the hIP is isoprenylated and palmitoylated, and collectively these modifications modulate its G protein coupling and effector signaling. We propose that through lipid modification followed by membrane insertion, the C-tail domain of the IP may contain a double loop structure anchored by the dynamically regulated palmitoyl groups proximal to transmembrane domain 7 and by a distal farnesyl isoprenoid permanently attached to its carboxyl terminus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12488443     DOI: 10.1074/jbc.M210637200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Molecular dynamics simulations reveal specific interactions of post-translational palmitoyl modifications with rhodopsin in membranes.

Authors:  Bjoern E S Olausson; Alan Grossfield; Michael C Pitman; Michael F Brown; Scott E Feller; Alexander Vogel
Journal:  J Am Chem Soc       Date:  2012-02-22       Impact factor: 15.419

Review 2.  A Review of Prostanoid Receptors: Expression, Characterization, Regulation, and Mechanism of Action.

Authors:  Roger G Biringer
Journal:  J Cell Commun Signal       Date:  2020-09-24       Impact factor: 5.782

Review 3.  Prostacyclin receptor regulation--from transcription to trafficking.

Authors:  C Midgett; J Stitham; K A Martin; J Hwa
Journal:  Curr Mol Med       Date:  2011-10       Impact factor: 2.222

4.  Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies.

Authors:  Hong Jiang; Xiaoyu Zhang; Xiao Chen; Pornpun Aramsangtienchai; Zhen Tong; Hening Lin
Journal:  Chem Rev       Date:  2018-01-02       Impact factor: 60.622

5.  Evidence for the presence of a critical disulfide bond in the mouse EP3γ receptor.

Authors:  Jason D Downey; Charles R Sanders; Richard M Breyer
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-01-12       Impact factor: 3.072

6.  Interaction of the human prostacyclin receptor with Rab11: characterization of a novel Rab11 binding domain within alpha-helix 8 that is regulated by palmitoylation.

Authors:  Helen M Reid; Eamon P Mulvaney; Elizebeth C Turner; B Therese Kinsella
Journal:  J Biol Chem       Date:  2010-04-15       Impact factor: 5.157

7.  Heterodimerization with the prostacyclin receptor triggers thromboxane receptor relocation to lipid rafts.

Authors:  Salam Ibrahim; Ann McCartney; Nune Markosyan; Emer M Smyth
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11-15       Impact factor: 8.311

8.  Palmitoylation of the TPbeta isoform of the human thromboxane A2 receptor. Modulation of G protein: effector coupling and modes of receptor internalization.

Authors:  Helen M Reid; B Therese Kinsella
Journal:  Cell Signal       Date:  2006-12-12       Impact factor: 4.315

9.  Regulation of the human prostacyclin receptor gene by the cholesterol-responsive SREBP1.

Authors:  Elizebeth C Turner; B Therese Kinsella
Journal:  J Lipid Res       Date:  2012-09-11       Impact factor: 5.922

10.  Immature and mature species of the human Prostacyclin Receptor are ubiquitinated and targeted to the 26S proteasomal or lysosomal degradation pathways, respectively.

Authors:  Peter D Donnellan; B Therese Kinsella
Journal:  J Mol Signal       Date:  2009-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.